PARIS, August 18 /PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions that accelerate life science discovery, announced the release today of the new software solution AurPROFILER(R).
AurPROFILER enables researchers to rapidly evaluate target, cell and drug profiles using bio-assays derived from the activity data found in Aureus Pharma's AurSCOPE Target Knowledge databases. AurPROFILER has been designed to work in conjunction with the just released AurSCOPE(R) Global Pharmacology Space and all of Aureus' drug target focused knowledge databases.
Compound profiling is routinely used by pharmaceutical researchers to evaluate the critical issues of drug target selectivity including off-target effects, polypharmacology and cytotoxicity. With easily interpretable graphics, AurPROFILER provides valuable insights to help better manage these issues by rapidly providing in-silico profiles. AurPROFILER results facilitate better discovery team decision making, and reduce risk to that streamline drug discovery projects. AurPROFILER was developed in collaboration with a pharmaceutical industry focus group consisting of several major pharmaceutical companies.
"After intensive development and customer validation, we are delighted to release AurPROFILER." said Jason Theodosiou, President and CEO of Aureus Pharma. "AurPROFILER is an example where the combination of Aureus' analysis capabilities and the high quality data within AurSCOPE Knowledge databases combine to bring additional value to researchers."
Aureus Pharma experts will demonstrate AurPROFILER at the American Chemical Society (ACS) meeting in Philadelphia, PA August 18th -21st.
About Aureus Pharma
Aureus Pharma headquartered in Paris, France is a privately held
knowledge management based solutions provider for the life sciences
industry. Aureus Pharma accelerates new drug discovery by providing
knowledge databases which contain high quality quantitative information for
both chemistry and biology. Researchers gain rapid access to knowledge for
important drug target classes as well as ADME/Tox topics. The information
contained in the Aureus Pharma system is of primary importance to aid in
lead discovery and optimization as well as to build predictive models.
Aureus delivers its information in the AurSCOPE format. The AurSCOPE
product line includes: AurSCOPE GPCR, AurSCOPE Ion Channel, AurSCOPE
Kinase, AurSCOPE Nuclear Receptors, AurSCOPE Proteases and AurSCOPE Global
Pharmacology Space. For further information on how Aureus Pharma helps
researchers turn data into discovery visit http://www.aureus-pharma.com.
Mary E. Donlan, Ph.D.
Director of Marketing
|SOURCE Aureus Pharma|
Copyright©2008 PR Newswire.
All rights reserved